Overview
Christine Becker is Co-Founder at Oova [1][3]. Becker holds a BSc in Biochemistry from the University of Galway [12] and a PhD in Biochemistry and Immunology from Trinity College Dublin [10], along with a Postgraduate Diploma in Statistics from Trinity College Dublin [11]. Becker's career includes positions as Post Doctoral Research Fellow at Harvard Medical School and Massachusetts General Hospital [9], Research Fellow at the Broad Institute and Harvard Medical School [8], Senior Scientist at Icahn School of Medicine at Mount Sinai [6], Assistant Professor at Icahn School of Medicine at Mount Sinai [5], and Adjunct Assistant Professor at Icahn School of Medicine at Mount Sinai [4]. Becker also served as Director of Preclinical Development at Ochre Bio [7] and currently holds the position of Director, Preclinical Development at Tangram Therapeutics [2].
Career history
- Director, Preclinical DevelopmentNov 2024 to presentTangram Therapeutics
- Co-FounderAug 2017 to presentOova
- Adjunct Assistant ProfessorMay 2022 to Jan 2025Icahn School of Medicine at Mount Sinai
- Assistant ProfessorOct 2018 to May 2022Icahn School of Medicine at Mount Sinai
- Senior ScientistNov 2015 to Oct 2018Icahn School of Medicine at Mount Sinai
- Director, Preclinical DevelopmentMay 2022 to Mar 2024Ochre Bio
- Research FellowSep 2013 to Nov 2015Broad Institute, Harvard Medical School
- Post Doctoral Research FellowFeb 2010 to Aug 2013Harvard Medical School, Massachusetts General Hopsital
Education
PhD, Biochemistry and Immunology2005 - 2010Trinity College Dublin
- BSc, Biochemistry2000 - 2004University of Galway
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.